Skip to content

Influence of Yiqi Daozhi Decoction on the recovery of intestinal function and autonomic nerve function after gastrointestinal cancer surgery

Influence of Yiqi Daozhi Decoction on the recovery of intestinal function and autonomic nerve function after gastrointestinal cancer surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000981
Enrollment
Unknown
Registered
2025-05-13
Start date
2024-01-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal cancer

Interventions

Control group:Oral placebo
Experimental Group:Yiqi Zhizhi decoction was taken orally

Sponsors

Affiliated Hospital of Nanjing University of Chinese Medicine (Jiangsu Province Hospital of Traditional Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Diagnostic criteria 1. Diagnostic criteria: The diagnosis of gastrointestinal cancer was based on the "Guidelines for the Diagnosis and Treatment of Gastrointestinal Cancer (2022 Edition)" issued by the National Health Commission of the People's Republic of China and the TNM staging of gastrointestinal cancer was based on the 8th edition of the American Joint Committee on Cancer (AJCC). Inclusion Criteria 1. Patients who met the above diagnostic criteria and completed laparoscopic gastric cancer surgery; 2. Age of 18-85 years old regardless of gender; 3. Voluntarily sign informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria 1. Patients with extensive metastasis or advanced malignant tumor who underwent palliative resection; 2. Pregnant or lactating women; 3. Previous history of gastrointestinal surgery; (4) patients with other malignant tumors within 5 years; 5. Combined with cardiovascular pulmonary renal brain and other serious primary diseases; 6. Patients with comorbid mental disorders; 7. Patients with peripheral nerve diseases; 8. Those who are participating in or have participated in other clinical trials that have an impact on this study within 1 month before this study; 9. Those who were allergic to the Chinese medicine decoction used in the study; 10. Conversion to laparotomy.

Design outcomes

Primary

MeasureTime frame
The first ventilation time after surgery;Recovery time of bowel sounds;The time of the first defecation after surgery;Time of first fluid diet after surgery;Indicators of autonomic nervous function;

Secondary

MeasureTime frame
Length of hospital stay after surgery;Markers of inflammation;Pain score after surgery (VAS);

Countries

CHINA

Contacts

Public ContactWang Gang

Affiliated Hospital of Nanjing University of Chinese Medicine

gwang82@163.com86+13390907882

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026